Ad is loading...
MENU

COLL Collegium Pharmaceutical Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products

COLL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
COLL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

COLL is expected to report earnings to rise 3.11% to $1.66 per share on February 20

Collegium Pharmaceutical COLL Stock Earnings Reports
Q4'24
Est.
$1.66
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.03
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.15
The last earnings report on November 07 showed earnings per share of $1.61, beating the estimate of $1.57. With 88.50K shares outstanding, the current market capitalization sits at 1.24B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Technology Center Drive
Phone
+1 781 713-3699
Employees
197
Web
https://www.collegiumpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECASX30.730.24
+0.79%
Eaton Vance Atlanta Capital SMID-Cap C
FSDPX99.950.57
+0.57%
Fidelity Select Materials
IMSCX37.330.04
+0.11%
IMS Capital Value
MUXRX29.50N/A
N/A
Victory S&P 500 Index R
PKSFX62.08N/A
N/A
Virtus KAR Small-Cap Core I

COLL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, COLL has been loosely correlated with SNDL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if COLL jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
+0.84%
SNDL - COLL
33%
Loosely correlated
-1.01%
SUPN - COLL
31%
Poorly correlated
+1.66%
ESPR - COLL
30%
Poorly correlated
N/A
ALKS - COLL
27%
Poorly correlated
+1.56%
ASRT - COLL
26%
Poorly correlated
-2.55%
More